Previous Close | 161.43 |
Open | 162.00 |
Bid | 162.35 x 1000 |
Ask | 161.83 x 900 |
Day's Range | 160.79 - 162.47 |
52 Week Range | 143.13 - 167.78 |
Volume | |
Avg. Volume | 7,233,625 |
Market Cap | 390.815B |
Beta (5Y Monthly) | 0.52 |
PE Ratio (TTM) | 24.60 |
EPS (TTM) | 6.60 |
Earnings Date | Oct 15, 2024 |
Forward Dividend & Yield | 4.96 (3.07%) |
Ex-Dividend Date | Aug 27, 2024 |
1y Target Est | 171.47 |
This leading pharmaceutical stock is flying under the radar right now.
In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $161.43, denoting a +0.79% change from the preceding trading day.
The approval is based on late-stage study data wherein treatment with J&J's (JNJ) Rybrevant plus Lazcluze cut the risk of disease progression or death by 30% in certain NSCLC patients.